文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

拔管预测评分(ExPreS)对ICU再插管的影响:一项随机对照试验

Effect of the extubation predictive score (ExPreS) on reintubation in the ICU: a randomized controlled trial.
PubMed 文献 · Crit Care · 2026-03-12
一句话结论单中心RCT(540例)中,ExPreS指导拔管使48小时内再插管率意向性分析从13.0%降至8.0%(p=0.070,未达统计学显著),符合方案分析降幅达统计学显著。

该研究为巴西一所大学医院两个ICU开展的单中心、前瞻性、平行组、随机对照优效性试验(2021年11月至2024年12月),纳入机械通气≥24小时且通过自主呼吸试验的成人,1:1随机分为标准方案拔管组与ExPreS算法(0-100分,含八项临床变量)指导拔管组。主要终点为48小时内再插管。意向性分析中对照组再插管13.0%、ExPreS组8.0%(绝对风险降低5.0%,相对降低38%,p=0.070);符合方案分析为对照组12.9%对ExPreS组7.3%(绝对风险降低5.6%,相对降低43%,p=0.042)。事后排除气道梗阻后ExPreS组再插管进一步降低(3.4%对9.1%,p=0.011)。机械通气时长、ICU住院时间和ICU病死率无差异。作者认为结果需谨慎解读,并需更大规模多中心研究确认。

要点

  • 通过自主呼吸试验的机械通气≥24小时成人中,意向性分析显示ExPreS组48小时内再插管8.0%,对照组13.0%,绝对风险降低5.0%,p=0.070,未达统计学显著。
  • 符合方案分析中ExPreS组再插管7.3%对对照组12.9%,绝对风险降低5.6%,相对降低43%,p=0.042。
  • 事后排除气道梗阻的分析中,ExPreS组再插管3.4%对对照组9.1%,p=0.011。
  • 机械通气时长、ICU住院时间与ICU病死率在两组间无差异。
  • 作者认为该结果需谨慎解读,并需更大规模多中心研究确认。

适用人群与场景

  • 巴西一所大学医院两个ICU中,机械通气≥24小时且通过自主呼吸试验的成人患者。
  • 单中心、前瞻性、平行组、随机对照优效性试验,2021年11月至2024年12月,按1:1随机分为标准方案组与ExPreS算法组。

诊断标准与关键阈值

  • ExPreS为拔管预测评分,分值范围0-100,包含八项临床变量。
  • 主要终点拔管失败定义为48小时内再插管。

研究设计与关键结果

  • 共随机540例(对照组267例,ExPreS组273例);主要终点48小时内再插管:意向性分析对照组13.0%对ExPreS组8.0%(绝对风险降低5.0%,相对降低38%,p=0.070)。
  • 符合方案分析:对照组12.9%对ExPreS组7.3%(绝对风险降低5.6%,相对降低43%,p=0.042)。
  • 事后排除气道梗阻的分析:ExPreS组3.4%对对照组9.1%,p=0.011。
  • 机械通气时长、ICU住院时间、ICU病死率两组无差异。

证据类型、等级与局限

  • 研究类型:单中心、前瞻性、平行组、随机对照优效性试验;注册号NCT05085457(2021年10月7日注册)。
  • 局限:作者自述结果需谨慎解读,并需在更大规模多中心研究中确认;主要意向性分析未达统计学显著。

对床旁实践的改变

  • 作者认为,与标准治疗相比,使用ExPreS与48小时内再插管率数值上更低相关,但主要意向性分析未达统计学显著,结果应谨慎解读并需更大规模多中心研究确认。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Extubation failure occurs in 10-30% of critically ill patients who successfully complete a spontaneous breathing trial (SBT) and is associated with worse clinical outcomes. The Extubation Predictive Score (ExPreS) was developed to assist clinicians in identifying patients at risk for extubation failure; however, its effectiveness as a decision-support tool has not yet been evaluated in a randomized controlled trial. We aimed to determine whether the use of ExPreS reduces reintubation within 48 h in mechanically ventilated adults.

METHODS: We conducted a single-center, parallel-group, prospective, randomized, controlled superiority trial in two ICUs of a Brazilian university hospital (November 2021-December 2024). Adults ventilated ≥ 24 h who passed an SBT were randomized (1:1) to extubation guided by a standard protocol or by the ExPreS algorithm (score range 0-100; eight clinical variables). The primary outcome was extubation failure, defined as reintubation within 48 h. Secondary outcomes included duration of mechanical ventilation, ICU length of stay, and ICU mortality.

RESULTS: A total of 540 patients were randomized (267 control, 273 ExPreS). In the intention-to-treat analysis, extubation failure within 48 h occurred in 13.0% of patients in the control group and 8.0% in the ExPreS group (absolute risk reduction 5.0%; relative reduction 38%; p = 0.070). In the per-protocol analysis, extubation failure occurred in 12.9% of controls and 7.3% of ExPreS patients (absolute risk reduction 5.6%; relative reduction 43%; p = 0.042). In a post-hoc analysis excluding airway obstruction, failure was further reduced with ExPreS (3.4% vs. 9.1%; p = 0.011). No differences were observed in duration of mechanical ventilation, ICU length of stay, or ICU mortality.

CONCLUSION: In this randomized controlled trial, use of the Extubation Predictive Score (ExPreS) was associated with numerically lower rates of reintubation within 48 h compared with standard care, although the primary intention-to-treat analysis did not reach statistical significance. Secondary and exploratory analyses showed a consistent direction of effect. These findings should be interpreted cautiously and warrant confirmation in larger multicenter studies.

TRIAL REGISTRATION: registered in ClinicalTrials.gov on October 07, 2021(NCT05085457).

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Oliveira JA, Klein F, Guzatti NG, et al. Effect of the extubation predictive score (ExPreS) on reintubation in the ICU: a randomized controlled trial. Crit Care. 2026. PMID: 41821078. doi:10.1186/s13054-026-05861-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。